Privacy-preserving platform providing regulatory-grade de-identified medical imaging data at scale for AI development and clinical research.
Segmed offers access to over 150 million de-identified medical imaging studies across CT, MRI, X-ray, ultrasound, PET/CT, and other modalities from 2,800+ healthcare partner sites across 50 US states and 5 continents. The platform serves life sciences R&D, medical device AI development, and clinical data management teams needing longitudinal and clinically validated datasets. Over 50 FDA-cleared products have been built using Segmed's data. Segmed is a product of Segmed.